Laparoendoscopic single‐site surgery for urachal remnant with extraperitoneal approach through a suprapubic port. Issue 3 (20th March 2022)

• Record Type: Journal Article
• Authors: Hoshi, Akio; Chihara, Ichiro; Shiga, Masanobu; Nitta, Satoshi; Nagumo, Yoshiyuki; Sakka, Shotaro; Kojo, Kosuke; Ikeda, Atsushi; Yoshino, Takayuki; Kimura, Tomokazu; Kawahara, Takashi; Kandori, Shuya; Negoro, Hiromitsu; Nishiyama, Hiroyuki
• Is Part Of: Asian journal of endoscopic surgery. Volume 15:Issue 3(2022)
• Page Start: 569
• Page End: 576
• Publication Date: 2022-03-20
• Subjects: extraperitoneal approach -- laparoendoscopic single‐site surgery (LESS) -- urachal remnant; Endoscopic surgery -- Periodicals; Endoscopic surgery -- Asia -- Periodicals; 617.05705
• DOI: 10.1111/ases.13056
• Languages: English
• ISSNs: 1758-5902

Abstract

Abstract: Introduction: No standard procedure has been established for laparoendoscopic single‐site surgery for urachal remnants (LESS‐U). This study aimed to report the novel surgical techniques and initial outcomes of laparoendoscopic single‐site surgery with an extraperitoneal approach through a suprapubic port for urachal remnants (spLESS). Methods: Fifty‐five patients (median age, 27 years; range, 15–69 years) who underwent LESS‐U were analyzed. To overcome the limitations inherent in the conventional procedure (LESS‐U through an umbilical port: uLESS), we modified the port placement and approached via the extraperitoneal space. spLESS is a novel procedure which reduces intestinal damage caused by the extraperitoneal approach and overcomes incomplete resection of the urachal remnant, especially in the bladder dome. Three trocars are inserted into the extraperitoneal space through a suprapubic port in spLESS, and complete resection of the urachal remnant from the umbilicus to the bladder is performed with an appropriate incision line. Patient characteristics and perioperative results were retrospectively collected. Cosmetic outcomes were prospectively evaluated using self‐administered questionnaires (body image and photo‐series questionnaire). Results: spLESS and uLESS were performed in 43 and 12 patients, respectively. No differences were observed between the perioperative results. The cosmetic outcomes were compared between the groups using body image and photo‐series questionnaires. No patient developed major complications; there was no recurrence in either group. Conclusions: spLESS is a novel procedure which can completely resect the urachal remnant and reduce the risk of intestinal damage. spLESS is a safe, effective, and feasible procedure with high postoperative cosmesis.